Financials data is unavailable for this security.
View more
Year on year Hofseth Biocare ASA grew revenues 61.79% from 120.45m to 194.87m while net income improved from a loss of 137.39m to a smaller loss of 106.68m.
Gross margin | 27.71% |
---|---|
Net profit margin | -55.65% |
Operating margin | -49.03% |
Return on assets | -34.79% |
---|---|
Return on equity | -134.48% |
Return on investment | -70.98% |
More ▼
Cash flow in NOKView more
In 2023, cash reserves at Hofseth Biocare ASA fell by 8.54m. Cash Flow from Financing totalled 3.69m or 1.90% of revenues. In addition the company generated 2.76m in cash from operations while cash used for investing totalled 14.99m.
Cash flow per share | -0.2332 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.2524 |
---|---|
Tangible book value per share | 0.1446 |
More ▼
Balance sheet in NOKView more
Current ratio | 0.7265 |
---|---|
Quick ratio | 0.3595 |
Total debt/total equity | 1.79 |
---|---|
Total debt/total capital | 0.6425 |
More ▼